Risk-benefit assessment

Risk control

Even if neither a graduated plan procedure nor a risk management plan is on the agenda for your medicinal products, it is well worth taking a snapshot of the current risk-benefit balance regularly. You might, for example, be reactivating an old marketing authorisation or thinking about in-licensing a third-party's  marketing authorisation to your own portfolio.

Marketing made to measure

We research and evaluate all available data on your active substance. We determine its risk-benefit balance in comparison to drugs with a similar mode of action. In doing so we take the assessments of medical societies, opinion leaders and supervisory authorities into account. Where necessary, we conduct detailed pharmacoepidemiological analyses.